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Machine Perfusion in Liver Transplantation 
as a Tool to Prevent 
Non-Anastomotic Biliary Strictures: 
Rationale, Current Evidence and Future 
Directions
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Robert J. Porte




The high incidence of non-anastomotic biliary strictures (NAS) after transplantation of livers from 
extended criteria donors is currently a major barrier to widespread use of these organs. This review 
provides an update on the most recent advances in the understanding of the etiology of NAS. These 
new insights give reason to believe that machine perfusion can reduce the incidence of NAS after 
transplantation by providing more protective effects on the biliary tree during preservation of the 
donor liver. An overview is presented regarding the different endpoints that have been used for 
assessment of biliary injury and function before and after transplantation, emphasizing on methods 
used during machine perfusion. The wide spectrum of different approaches to machine perfusion is 
discussed, including the many different combinations of techniques, temperatures and perfusates 
at varying time points. In addition, the current understanding of the effect of machine perfusion 
in relation to biliary injury is reviewed. Finally, we explore directions for future research such as 
the application of (pharmacological) strategies during machine perfusion to further improve 
preservation. We stress the great potential of machine perfusion to possibly expand the donor pool 
by reducing the incidence of NAS in extended criteria organs. 
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INTRODUCTION 
Orthotopic liver transplantation is currently the only available life-saving treatment for patients with 
end-stage liver disease. Unfortunately, the number of organs needed for transplantation greatly 
surpasses the supply, prompting strict selection criteria for transplant candidates and long waiting 
lists for those patients that reach candidate status. As a result of this shortage about 15% of patients 
die while on the waiting list.1 Additionally, according to studies of death certificates, about 60,000 
patients die of liver disease annually in the United States2; many of whom could (theoretically) have 
been treated with a liver transplant. When only waitlist mortality is considered, the magnitude of 
the problem of end-stage liver disease is grossly underestimated. In fact, only about 1.5% of liver 
disease related mortality concerns waitlisted patients.3 
The grave shortage of livers available for transplantation causes the transplant community to 
continuously push the boundaries to increase the availability of organs. As a part of this effort, 
criteria for donor liver selection have been progressively expanded, allowing the usage of more 
suboptimal or compromised grafts. Livers from donors that fall outside of standard criteria, also 
known as ‘extended criteria donors (ECDs), are increasingly considered for transplantation during 
the past decades.4 For example, in the United Kingdom 42% of transplanted livers now come from 
donation after circulatory death (DCD) donors, as opposed to donation after brain death (DBD).5 
The most important other criteria that are being widened include donor age, blood type ABO 
incompatibility, steatosis, and infectious diseases in the donor.6,7 The increased acceptance of livers 
from ECDs in the past two decades has contributed significantly to the expansion of the donor 
organ pool.8,9 
Today, the survival rate of patients that receive a DCD liver graft is approximately similar to 
DBD recipients.10-13 However, the transplantation of DCD liver grafts is associated with around 10% 
lower 1-year graft survival rate, compared to DBD livers and a markedly higher incidence of biliary 
complications.14-17 The incidence of non-anastomotic biliary strictures (NAS) varies between 4 and 
15% after transplantation of DBD livers, but can be as high as 30%-50% after transplantation of DCD 
grafts.17,18 The occurrence of NAS in a donor liver critically impacts patients’ long-term survival, rate 
of re-transplantation, quality of life and the cost of care.19,20 Synonyms for NAS that are frequently 
used in the literature are ischemic–type biliary lesions and ischemic cholangiopathy. In general, 
all three names refer to the same clinical entity characterized by a combination of narrowing and 
dilatations (or even intraparenchymal leakage) of the larger intra- and extrahepatic donor bile 
ducts, either with or without intraluminal sludge and cast formation, and in the presence of a patent 
hepatic artery (Figure 1A and B). Severity and distribution of NAS along the biliary tree may vary 
considerably among patients and clinical symptoms range from no symptoms to recurrent jaundice 
and/or life-threatening cholangitis with subsequent need for re-transplantation.21
NAS is a feared and severe complication in DCD liver transplantation, resulting in a considerable 
number of donor livers that are currently being rejected for transplantation, while these livers 
could potentially be used if a protective method against the development of NAS existed. Machine 
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Figure 1. Radiological and histological examples of bile duct injury in a donor liver. (A) Cholangiogram revealing 
mild non-anastomotic strictures in a donor liver. (B) Cholangiogram showing severe non-anastomotic strictures in a 
donor liver. (C) Histology of a donor bile duct (hematoxylin & eosin staining) with approximately 50% detachment and 
loss of the luminal epithelium (lumen indicted by #), but well preserved bile duct wall stroma (asterix) and peribiliary 
glands (dotted lines). (D) Histology of a donor bile duct (hematoxylin & eosin staining) with a well preserved arteriole 
(arrow) as part of the PVP. (E and F) Histology of a donor bile duct (hematoxylin & eosin staining) with necrosis of 
bile duct wall stroma (asterix), arteriolonecrosis, and loss of epithelial cells in the peribiliary glands (dotted lines). The 
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perfusion is a promising technique that has gained renewed interest in the past decade as a tool 
to optimize and assess livers for transplantation. Protection of the biliary tree as a specific target of 
machine perfusion has, however, been underexposed in the literature. In this review we provide 
an update on the most recent advances in the understanding of the etiology of NAS and present 
current evidence supporting the hypothesis that machine perfusion reduces bile duct injury during 
transplantation, providing a tool to reduce the incidence of NAS. Moreover, we provide an overview 
of endpoints used for evaluation of the biliary tree in the setting of machine perfusion. 
Risk factors and pathogenesis of NAS
Traditionally, the degree of biliary injury that occurs during and after transplantation was considered 
to be the main determining factor for NAS.22 Warm and cold ischemia, reperfusion injury, bile salt 
toxicity, and immune-mediated injury have been identified as the most important contributors 
to this multifactorial process of biliary injury.18,23 However, three independent histological studies 
focusing on the common bile duct of donor livers revealed that in 86%-88% of cases the bile duct 
epithelium is already significantly injured at the end of cold storage.24-26 This observation indicates 
that the bile ducts of almost every donor liver suffer substantial injury during graft preservation, yet 
only a minority of them develop NAS after transplantation, suggesting that the (lack of ) regenerative 
capacity of the donor bile duct may be more important than the initial degree of injury.26
This new concept of the pathogenesis of NAS has incited interest into the mechanisms involved 
in biliary regeneration. In a study of 128 liver transplants, op den Dries et al27 have demonstrated a 
strong association between injury of the peribiliary glands (PBG) and the peribiliary vascular plexus 
(PVP) at the time of transplantation and the later development of NAS in liver transplant recipients. 
The PBG are glandular structures that are abundantly present in the wall of the extrahepatic and 
major intrahepatic bile ducts, which are the most common locations of stricture formation.21,28 
Moreover, the PBG have been shown to be a niche for progenitor cells that can proliferate upon 
biliary injury.28-32 The fact that i) extensive epithelial regeneration is necessary after transplantation 
in the majority of liver grafts; ii) proliferation is observed in the PBG upon biliary injury and iii) loss 
of PBG integrity at the time of transplant is associated to the development of NAS post-transplant 
strongly suggests that the PBG are a key component required for successful recovery from the 
extensive and multifactorial biliary injury that occurs during transplantation. Possibly, the absence 
of a healthy epithelial barrier due to the failure of cholangiocyte regeneration increases (prolonged) 
bile salt cytoxicity and inflammation eventually leading to NAS.18,23,27,33 
The PVP is essential for the viability of the bile duct as it provides blood with nutrients and 
oxygen to the bile ducts. Blood flow through the PVP is mainly supplied by the hepatic artery and 
thrombosis of the hepatic artery early after transplantation generally leads to necrosis of the larger 
donor bile ducts.34-36 Even in the presence of a patent artery, dysfunction and preservation injury of 
the PVP is believed to play a role in the etiology of NAS.24,37 These recent findings suggest a critical 
role of the PVP and the PBG in biliary regeneration and the pathogenesis of NAS. Histology of bile 
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ducts with various degrees of injury of the luminal biliary epithelium, the PBG, and the PVP are 
presented in Figure 1C-F. The regenerative capacity of the bile duct may be negatively influenced by 
known risk factors for NAS, such as donor age and donor warm ischemia (as occurs in DCD donors), 
as well as toxic bile salts that may not only affect the luminal epithelium, but also the PBG and PVP. 
Especially when the luminal biliary epithelium is absent, bile salts can easily enter the bile duct wall 
Figure 2. Proposed pathogenesis of non-anastomotic biliary strictures (NAS) after liver transplantation. 
During warm (in DCD donors) and cold ischemia (in both DCD and DBD livers) bile duct injury occurs almost universally, 
characterized by injury and loss of the luminal biliary epithelium. This type of injury alone does not necessarily lead 
to NAS. Critical components of the bile duct wall are the peribiliary glands (PBG) and the peribiliary vascular plexus 
(PVP). Severe injury to the PBGs and PVP has been associated with the development of NAS27 suggesting that adequate 
preservation of these stuctures is essential for a timely regeneration of the biliary epithelium. After transplantation, 
biliary bile salts may cause additional damage to the remnant luminal epithelium and diffuse into the bile duct wall, 
causing injury to the PBG and PVP. Secondary influx of immune cells leads to inflammation with subsequent fibrosis 
and scarring of the bile ducts resulting in NAS. Machine perfusion of donor livers may reduce the incidence of NAS after 
transplantation by reducing the amount of injury to the various components of the bile duct wall. 
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stroma and cause injury to these essential structures. Achieving protection or improved recovery 
of these critical components of the bile duct wall by machine perfusion could therefore contribute 
to the prevention of NAS. Here, preventing injury altogether would be the ultimate target, because 
when regeneration is not needed it also cannot fail. If this cannot be accomplished, protection of 
the PVP and PBG to facilitate successful regeneration through tissue oxygenation and preservation 
of progenitor cells in the PBG are obvious subsidiary goals. Not surprisingly, optimal preservation 
of the PVP and PBG has become an important endpoint in machine perfusion studies.38-40 The 
proposed pathogenesis of NAS and the various targets for machine perfusion are summarized in 
Figure 2.
Assessment of the impact of machine perfusion on the biliary tree
Accurately assessing the effect of machine perfusion on the biliary tree poses a significant 
challenge. Biliary function and injury are frequently used as surrogate endpoints for the occurrence 
of NAS. However, in general the overall degree of biliary injury does not correlate very well with the 
development of NAS.26 Unfortunately, NAS do not easily occur after liver transplantation in rats and 
therefore this definitive endpoint is only obtainable in transplantation studies of large animals or 
humans, which are more complex and expensive. Nevertheless, a worthy set of endpoints, based on 
the current understanding of the etiology of NAS, is available for evaluating the biliary tree in the 
setting of machine perfusion (Table 1). 
As discussed previously, multiple studies have indicated an important role of the PVP and PBG 
in the etiology of NAS.24,27,37 Therefore, the effects of machine perfusion on these structures are of 
particular relevance. They can be investigated using standard light microscopy and a standardized 
semi-quantitative scoring system.24,25,27 This approach is significantly more objective compared 
to free-format pathological interpretation and has emerged as an important endpoint.38,39 More 
sophisticated methods such as immunohistochemistry may also be used. For example, Ki67 and 
CK19 are markers for proliferation in the PBG and the bile duct epithelium respectively.32,38,41 
The expression of von Willebrand Factor on the vascular endothelium indicates endothelial cell 
activation that can lead to platelet aggregation in the PVP.38
Bile salt toxicity is known to be another important pillar in the mechanism of NAS.18 The 
epithelial lining forms a specialized barrier to protect the bile duct from the detergent effects of 
bile. Hepatocytes excrete phospholipids that form mixed micelles, neutralizing the detergent effect 
of bile salts. When this barrier is impaired by ischemia/reperfusion induced injury or dysfunction, 
toxic bile salts can cause additional harm to the biliary epithelium, or when this is already absent, 
to the unprotected sub-mucosal stroma and the deeper located structures such as PBG and PVP.33,42 
Consequently, the ratio of bile salts to phospholipids in bile during perfusion is an important marker 
of the endogenous protective mechanisms against bile salt toxicity. The same is true for the biliary 
concentration of bicarbonate (HCO3
-), which prevents the protonation of biliary glycine-conjugated 
bile salts and uncontrolled cell entry of the corresponding bile acids through cell membranes 
54
Chapter 4
by raising the pH, a phenomenon known as the “bicarbonate umbrella”.43 Bicarbonate is actively 
secreted into the bile by the biliary epithelial cells (or cholangiocytes) and, therefore, biliary 
bicarbonate concentration can also be used as a biochemical marker of cholangiocyte function.18 
Moreover, disruption or imbalance of bile salt transportation, which is an adenosine 5'-triphosphate 
(ATP) dependent process, can contribute to injury by the intracellular accumulation of hydrophobic 
bile salts.44,45
The production of bile involves a cascade of steps that requires good function of all its 
components, including both hepatocytes and cholangiocytes.46 Therefore, the rate of bile production 
during machine perfusion, in combination with the characteristics of its composition, is an excellent 
Table 1. Overview of endpoints suitable for studying biliary preservation by machine perfusion
Endpoint Variable Level of 
evidence*
References
Non-anastomotic biliary strictures (NAS)
ERCP or MRCP (gold standards) IIa  21,115
PTCD IIa  116
Plastination casting (animal model) III  117
Established risk factors for NAS
H&E staining/systematic light microscopic evaluation of common bile duct biopsies at time of 
transplantation
PVP injury III  24,27
Deep PBG injury III  27
Mural stroma necrosis III  24,25,27
Cholangiocyte loss III  25
Bile salt / phospholipid ratio in bile III  33,42
Cholesterol in bile III  33
Cholangiocyte specific microRNAs
In bile III  42,52
In preservation fluid III  118
Indicators of biliary injury with unknown correlation to NAS
Immunohistochemistry of bile duct biopsies
Markers of apoptosis V  109
Ki-67 protein V  32,38
Von Willebrand Factor V  38
Loss of cytokeratin 19 (CK19) positive cells V  41
Cholangiocyte function markers in bile
Bicarbonate V  38,50,74
pH V  74
Glucose V  119
Cholangiocyte injury markers in bile
Gamma-glutamyltransferase III 38,50,77,98,120
Lactate dehydrogenase III 38,50,98,120
* Level of evidence assessed according to Oxford 2011 levels of evidence119.
Abbreviations: ERCP, Endoscopic Retrograde Cholangiopancreatography; MRCP, Magnetic Resonance 
Cholangiopancreatography, PTCD, percutaneous cholangiography drainage; H&E, hematoxillin and eosin, PVP, 
peribiliary vascular plexus, PBG, peribiliary gland.
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indicator of both liver and biliary function.47 Glucose is initially present in the canalicular bile at a 
concentration equal to plasma and is subsequently reabsorbed by the cholangiocytes of the bile 
ducts. A low glucose concentration (< 1.0 mmol/L) in the common bile duct bile, therefore, indicates 
adequately functioning biliary epithelial cells, and can be used as a target for assessing bile duct 
integrity during machine perfusion.48,49
Markers of cellular injury, such as lactate dehydrogenase and gamma-glutamyltransferase, 
can be measured in bile and perfusate.38,50 Although they may reflect the degree of biliary injury, 
it is unknown whether high biliary levels of these injury markers are associated with the later 
development of NAS. One method that holds promise is the detection of cholangiocyte specific 
micro RNAs in bile that have been associated with the development of NAS.51,52
Obviously, the incidence of NAS during follow up after transplantation of machine-perfused 
grafts is the most relevant endpoint in determining the effect of machine perfusion on biliary 
complications. Randomized clinical trials are needed to elucidate the effect of machine perfusion 
on biliary complications in humans.
Machine perfusion: a spectrum of techniques
The term ‘Machine perfusion’ is very broad; it covers a spectrum of techniques with mechanical 
perfusion as their common denominator. Fundamentally, the configuration of machine perfusion 
depends on three parameters: the timing and duration of its application, and the perfusion 
temperature. In order to prevent endothelial shear stress, pressure controlled perfusion is considered 
to be a safer method compared to flow controlled perfusion.53
Perfusion through the portal vein only is feasible at low temperatures.54,55 But from the perspective 
of biliary preservation, arterial perfusion and the delivery of oxygen to the bile ducts seems 
paramount because the biliary system depends mainly on the arterial circulation.40,56 Additionally, 
oxygenated perfusion of the arterial system has been described to attenuate arteriolonecrosis of 
the PVP and therefore may contribute to preservation of the vasculature to the bile ducts.39 On the 
other hand, it should be noted that in contrast to traditional belief, blood is also supplied to the bile 
ducts by the portal vein57 and insufficient portal perfusion should also be considered a risk factor for 
the development of NAS.58,59 An argument against cannulation and perfusion of the hepatic artery 
is the potential risk of causing intima injury or vascular dissection. This risk can be minimized by 
using a cylindrical aortic segment for cannulation, which can be cut off and discarded at the end of 
perfusion before implantation.
Machine perfusion can be applied at different time points during the process of procurement, 
transportation, and transplantation, as summarized in Figure 3. The earliest possible application of 
machine perfusion in the chain of events is in situ normothermic regional perfusion (NRP) in the 
donor, immediately after circulatory arrest. It offers the advantage of restoring cellular levels of ATP 
that have become depleted during the period of warm ischemia by restoration of normothermic 
circulation in the donor prior to standard cold storage.60 The technique has been successfully used 
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in clinical DCD organ donation, and its effect on preservation of the bile ducts and the rate of 
biliary complications seems promising.61-63 Investigators from the Hospital Clinic in Barcelona have 
reported 42 liver transplant procedures after NRP of DCD donors with a biliary complication rate of 
17%.63 Another group, from the University of Michigan, has described 13 liver transplant procedures 
using this method with an incidence of biliary complications of 14%.62 While these outcomes are 
very hopeful, both studies lacked a control group and were not randomized. Also, in one report 38% 
of donor livers were discarded because of technical complications, illustrating the complexity of 
NRP.62 Randomized controlled trials are necessary to assess the clinical benefits of NRP.
Ex situ machine perfusion of the liver can be performed at the donor site before cold storage 
(pre-storage perfusion), at the receiving hospital after cold storage prior to implantation (end-
ischemic perfusion), or throughout the preservation period (preservation perfusion) (Figure 3).64,65 
The advantage of pre-storage perfusion is that it has the ability to restore the energy charge of the 
liver prior to subjecting it to cold ischemia, potentially reducing the synergistic accumulation of 
injury caused by subsequent warm and cold ischemia. However, accomplishing on-site machine 
perfusion in donor hospitals is troubled by several logistical challenges. 
These challenges are even more pronounced in preservation perfusion, which requires a machine 
perfusion device that is portable and self-sufficient for the duration of the preservation period. 
Theoretically, continuous preservation perfusion is the most optimal choice because it eliminates 
the need for cold storage. Normothermic preservation perfusion has been successfully used in a 
clinical trial including liver transplantation of ten patients.66 Although continuous normothermic 
preservation perfusion may prove to be the most effective preservation method in the future, it is 
questionable whether complete elimination of cold preservation is necessary and cost-effective in 
the current era. 
End-ischemic perfusion offers the advantage that it can be performed in the environment 
of the transplant center with all the logistic support needed for successful perfusion. Although 
logistically appealing, irreversible injury may have occurred already to the liver and the biliary tree, 
which might have been preventable or treatable upon earlier intervention. Finally, through both 
Figure 3. Schematic presentation of the various dimensions of machine perfusion. Abbreviations: DCD: donation 
after circulatory death, NRP: normothermic regional perfusion.  
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preservation perfusion and end-ischemic perfusion, the organ can be optimized immediately prior 
to implantation, which is not the case for pre-storage perfusion. In general, machine perfusion 
requires specific surgical training and the direct costs are higher compared to simple cold storage. 
However, the technique could be cost-effective and even lead to lower overall costs due to shorter 
postoperative length of stay and reduction of the incidence of NAS, but studies of cost-effectiveness 
are needed to clarify this. Promisingly, renal machine perfusion has been proven to be cost-
effective.67,68
Temperature
The cellular rate of respiration is greatly dependent on the temperature, following an exponential 
curve.69 Simple static cold storage at 0-4 °C is based on this principle and reduces the metabolic rate 
of the liver to about 5% of the physiological level. Because of this relationship, the temperature used 
during machine perfusion dictates the calibration of most other perfusion parameters that should 
be optimized to meet the dynamics and metabolic needs of the organ at a given temperature. 
Hypothermic machine perfusion
Under hypothermic conditions (0-10°C), the use of an acellular perfusion fluid at low pressures is most 
common. The use of red blood cells or an oxygen carrier is not necessary, because adequate uptake 
of oxygen into the fluid can be achieved through diffusion at low temperatures.70 Hypothermic 
machine perfusion (HMP) is safe because in case of pump failure, the organ falls back on the ‘default’ 
conditions of static cold preservation. The low metabolic activity that is associated with hypothermic 
perfusion conditions also forms a limitation, because it does not allow a functional assessment of 
the liver. For example, the liver does not produce bile during HMP, which is an important indicator 
of hepatobiliary function and allows biochemical assessment of biliary markers of biliary epithelial 
cell function and injury.50,71
A large number of studies using HMP in animal models have been performed; however, few 
studies have evaluated the effects of HMP on the biliary system.53 Using a non-arterialized model of 
DCD liver transplantation in rats, Schlegel et al41 compared one hour of end-ischemic hypothermic 
oxygenated machine perfusion to cold storage alone. After four weeks of follow up, animals from 
the HMP group presented with superior histological appearance of the intrahepatic bile ducts 
and significantly lower serum gamma-glutamyltransferase, alkaline phosphatase and bilirubin.41 
In another experimental study, our group has compared 4 hours of hypothermic oxygenated 
perfusion to cold storage of DCD pig livers, followed by 2 hours of normothermic blood reperfusion 
to simulate transplantation. Although, no differences in biliary epithelial function or injury were 
observed, oxygenated HMP did lead to superior preservation of the PVP, which may have a positive 
impact on blood supply to the bile ducts and their regenerative capacity after transplantation.39
Guarerra and coworkers, who were the first to describe successful clinical transplantation of 
HMP preserved liver grafts in 201054, recently reported the outcome of the first 31 cases performed 
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in their center.70 Apart from generally improved outcome parameters (shorter length of stay, lower 
postoperative serum injury markers etc.), the number of biliary strictures in the HMP preserved 
group was significantly lower compared to matched controls (10% after HMP vs. 33% after SCS). 
It should be noted that the perfusion system used by Guarerra and coworkers does not provide 
active oxygenation of the perfusion fluid and the duration of perfusion was not standardized. 
Dutkowski et al55 have applied oxygenated HMP, or Hypothermic Oxygenated PErfusion (HOPE), to 
eight locally procured DCD livers before transplantation and compared the outcomes with matched 
DBD controls. The rate of biliary complications was identical between the two groups; however, the 
numbers were too low to draw any robust conclusion on the incidence of biliary strictures. Despite 
the fact that livers were perfused through the portal vein only and the study lacks a DCD control 
group, it suggests a possible protective effect of HOPE against bile duct injury. A clinical trial with 
hypothermic oxygenated dual perfusion of DCD livers (through both the portal vein and hepatic 
artery) was recently initiated in our center (Netherlands Trial Registry, NTR4493; www.trialregister.
nl). Final assessment of the efficacy of HMP (either oxygenated or non-oxygenated) in reducing 
biliary injury and subsequent NAS should come from large multi-center randomized clinical trials. 
Several initiatives to organize such trials have been taken (i.e. ClinicalTrials.gov, ID: NCT01317342).
Subnormothermic machine perfusion
Subnormothermic machine perfusion (SNMP, 20–30 °C) is a middle-of-the-road approach between 
HMP and normothermic machine perfusion (37 °C, NMP).73 An advantage of SNMP is its relative 
simplicity compared to NMP. By inducing a metabolic rate of approximately 25% of physiological 
levels, it allows for functional assessment of the liver.74 To prevent depletion of nutrients, SMP 
requires the use of a nutrient enriched perfusate. Surprisingly, an oxygen carrier is not always used; 
SMP has been performed both with and without red blood cells or an artificial oxygen carrier.73,75,76 
The question whether the use of an oxygen carrier at subnormothermic temperatures is essential, 
therefore, remains a matter of debate and this issue requires further research.
SNMP has been tested in rats with positive effects on bile production and decreased release 
of biliary enzymes.77,78 Using a hepatocyte cell culture medium as a perfusate, Bruinsma et al74 
performed SNMP of seven human livers that were declined for transplantation. During 3 h of end-
ischemic SNMP, increasing bile flow and biliary bicarbonate excretion were seen. Moreover, the ratio 
of bile salts to phospholipids in bile decreased over time, indicating improvement of hepatocellular 
secretory function and a decrease in bile toxicity. Unfortunately, this study had no control group or 
reperfusion phase; therefore, it provides little substantiation for SNMP beyond proof of feasibility.74
Knaak et al79 have performed liver transplantation after SNMP of DCD pig livers, comparing it 
to static cold storage. The three-hour perfusion phase in this experiment, using Steen’s solution 
with washed red blood cells at 33 °C, was preceded by four hours, and followed by three hours 
of cold ischemia time. The investigators first studied bile output of the liver during eight hours of 
in situ reperfusion. Subsequently, ten animals (five vs. five) were transplanted and monitored for 
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seven days. Lactate dehydrogenase in the bile was found to be significantly lower immediately after 
transplantation in the SNMP group. Moreover, cold stored grafts presented with substantial bile 
duct necrosis after seven days, but those that preserved with SNMP did not. This was also reflected 
in the serum levels of alkaline phosphatase during the survival period, which were significantly 
higher in the cold storage group. This study indicates that SNMP has protective effects on the bile 
ducts in a DCD model of pig liver transplantation.
Normothermic machine perfusion
Under normothermic conditions, the liver reaches a physiological metabolic rate and functionality. 
Sufficient oxygen delivery can only be achieved with the use of an oxygen carrier. This form of 
machine perfusion has been studied extensively in experimental models by the group of Friend 
and coworkers66,71,80,81 and enables ex situ viability testing of the liver.50 Some argue that it is superior 
to cold perfusion because it provides the closest resemblance to the normal physiological situation 
in vivo.82 However, bringing the organ up to ‘full metabolic speed’ also makes it more vulnerable. 
Interruption of perfusion or insufficient oxygen delivery will immediately expose the liver to 
warm ischemia. Remaining mindful of this risk, NMP can be safe and reliable when performed 
correctly.83,84,85,86
NMP appears to be the category of perfusion that provides the most pronounced effects on 
biliary preservation. In an interesting experiment using pig DCD livers, Liu et al38 assessed the effect 
of 10 h of NMP on biliary injury and regeneration during 24 h of ex vivo reperfusion. The study 
showed lower release of injury markers (gamma-glutamyltransferase and lactate dehydrogenase) 
in bile and increased biliary bicarbonate secretion in NMP preserved livers, compared to livers that 
underwent conventional 10 h of static cold storage. Moreover, NMP preserved livers displayed 
significantly less histological injury of the PBG and PVP, produced more bile, and demonstrated lower 
thrombogenicity of the microvasculature. Additionally, using Ki-67 staining, these investigators 
observed proliferation of cholangiocytes during 24 h of reperfusion of NMP preserved grafts, which 
was not seen in livers preserved by static cold storage. This study provides important evidence that 
10 h of NMP yields superior results with regard to biliary injury and regeneration, compared to static 
cold storage.38 It should however, be noted that this study did not include actual transplantation 
of machine-perfused livers and, therefore, the occurrence of NAS after transplantation was not 
assessed.
Boehnert et al87 have published an experimental study showing extraordinary biliary 
preservation by NMP in a DCD pig model. Although their experiment offers new perspectives on 
NMP, such as through the use of CT angiography, this study has been criticized for its design and 
difficulty to explain the outcomes.88,89 Our group was the first to publish on the feasibility of NMP 
in four discarded human livers using six hours of perfusion in an end-ischemic approach.50 During 
the six hours of NMP, bile duct histology remained well preserved and did not deteriorate. After 
expanding this series to a total of 12 livers, we found that bile production during NMP can be used 
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as a predictor of graft function, enabling viability testing.47 This finding is in line with previous 
animal studies of NMP, which have recognized bile production as a critical parameter of viability of 
the perfused liver.71,83,90
Several (randomized) clinical trials have been initiated recently and hopefully these studies 
will provide evidence for the beneficial effects of machine perfusion on the incidence of 
biliary complications after liver transplantation. In one randomized controlled multicenter trial 
normothermic preservation perfusion will be compared with static cold storage (http://www.
controlled-trials.com/ISRCTN39731134/). Another multicenter trial is investigating the possible 
protective effects of normothermic regional perfusion in DCD donors (http://www.controlled-trials.
com/ISRCTN89667087/). 
Controlled rewarming
The abrupt change in temperature that occurs upon reperfusion during transplantation of a 
hypothermic liver is believed to contribute to reperfusion injury. Many research groups have 
explored machine perfusion strategies at a constant temperature, still exposing the liver to sudden 
temperature changes. Minor et al studied the effect of controlled oxygenated rewarming (COR) 
of the liver from ice-cold to subnormothermic temperatures during perfusion and compared this 
method with HMP and SNP alone.91 In this experiment, pig livers were harvested and preserved 
by cold storage for 18 h, followed by 90 min of SNP, HMP or COR. The organs where subsequently 
re-perfused ex vivo normothermically with autologous blood to simulate transplantation. Energy 
charge restoration during COR was similar to SMP, but superior to HMP. In addition, COR was 
associated with significantly better hepatobiliary function (as indicated by bile production) and less 
injury upon reperfusion. A group from Tokyo has described similar results.92,93 Integrating controlled 
rewarming into perfusion protocols could potentially combine the best of cold and warm perfusion 
techniques and may potentially provide better protection of the bile ducts.
Perfusate composition
The composition of the perfusion fluid is guided primarily by the temperature, timing and duration 
of machine perfusion. Whereas at low temperatures a low-nutrient preservation solution may be 
used, increasing duration and temperature of perfusion necessitates more additives. Irrespective of 
these factors, oxygen delivery through the perfusate is a fundamental pillar of the advantages that 
machine perfusion has to offer to both the liver and the bile ducts.56,94-96 When oxygen consumption 
exceeds the delivery potential of dissolved oxygen in a watery fluid, red blood cells or an artificial 
oxygen carrier should be added.38,50,97 Because the hepatobiliary transporters that are responsible 
for bile formation are calcium dependent, it is important to titrate calcium to physiological levels 
for the optimization of biliary secretory function.46,98 This is especially true when blood products 
are added to the perfusate, which usually contain calcium-scavenging agents such as citrate. Bile 
salts excreted by the liver during machine perfusion do no return to the perfusate, which normally 
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happens through the enterohepatic circulation in vivo. Supplementation of bile salts is therefore 
necessary when applying machine perfusion for extended periods of time to ensure sustained bile 
production.71 Another relevant aspect is the viscosity of the solution. Several studies have indicated 
that low-viscosity solutions may achieve superior perfusion of the peribiliary vasculature.99-102 
However, the effect of low-viscosity cold flush solutions on biliary complications is controversial.103 
Other constituents of machine perfusion solutions may be oncotic agents (e.g. albumin), parenteral 
nutrition, antibiotics, insulin, heparin, and vasoactive drugs.38,50,104 Machine perfusion also opens 
alleyways towards ex situ treatment of the liver to enhance the preservation even further. As these 
techniques are still speculative, they will be discussed as ‘future directions’.
Many combinations of perfusion temperatures, perfusates, time points and durations have been 
explored. For a more detailed overview of particular configurations, we suggest further reading of 
specific reviews.53,105-108 Which combination of these parameters provides optimal protection for the 
biliary tree currently remains unclear. 
Future directions
Machine perfusion provides a platform that may facilitate the treatment of donor livers, uncovering 
specific targets that previously remained out of reach for the transplant surgeon. One possibility 
that quickly comes to mind is the addition of pharmacological agents to the perfusion fluid. Such 
interventions could be specifically targeted at factors that have been shown to play a role in the 
pathogenesis of NAS, such as bile composition, immunological factors, bicarbonate secretion, or 
even factors that may stimulate biliary epithelial regeneration. 
With the aim of reducing the Kupffer cell-mediated insult to the liver after transplantation, one 
group has administered gadolinium chloride (GdCl3) to rats in an autologous rat transplant model. 
This intervention reduced the amount of apoptosis observed in the bile duct after warm ischemia/
reperfusion injury.109 Another prospect could be the addition of hydrophilic bile salts or other 
compounds to stimulate a less cytotoxic bile composition.71
Finally, it has been proposed that the infusion of mesenchymal stem cells (MSCs) into the 
perfusion circuit could help restore a donor organ.110 Although the exact mechanisms are unknown, 
MSCs are believed to have anti-inflammatory and pro-regenerative effects mostly through the 
excretion of paracrine factors without requiring colonization.111,112 The clinical safety of MSC infusion 
in liver transplant recipients has been suggested, but the efficacy is still strongly debated.113,114 
Machine perfusion provides an exceptional opportunity for the ex situ application of MSCs.
Conclusion
Liver machine perfusion comprises a spectrum of promising techniques of liver graft preservation 
that are currently making the transition into clinical practice. It is anticipated that the use of 
machine perfusion can lead to a significant increase of the availability of transplant livers as well as a 
reduction in postoperative complications such as early graft dysfunction and biliary complications. 
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Existing data from animal models and preliminary data from (discarded) human donor livers provide 
promising evidence that machine perfusion has relevant protective effects on the bile ducts. In 
animal studies, liver machine perfusion did not only reduce the amount of injury to the bile ducts, 
but it also helped to restore the endogenous regenerative capacity of the biliary epithelium and bile 
duct wall. Whether this results in a decreased incidence of biliary complications, such as NAS, after 
clinical transplantation needs to be awaited. Randomized clinical trials are being initiated and will 
be necessary to demonstrate the efficacy of machine perfusion in clinical transplantation. Finally, 
machine perfusion provides a platform for the exploration of putative ex situ treatments, using 
interventions that are aimed at specific targets in the liver and the biliary system.
Key points
• Non-anastomotic biliary strictures (NAS) are a major barrier 
for the widespread use of extended-criteria donor livers. 
• Considerable progress has been made in the understanding 
of NAS. 
• Surrogate endpoints have been identified to study the 
protective effect of machine perfusion on the biliary tree. 
• Machine perfusion comprises a spectrum of techniques; 
different forms of machine perfusion offer protective effects 
on the biliary tree and may prevent NAS. 
• Machine perfusion holds great promise to expand the donor 
pool by improving the quality of extended criteria donor 
livers and reducing the incidence of NAS
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